Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00851253 · ClinicalTrials.gov registry record · NA
Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00851253 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 12 participants.
The verdict
NCT00851253, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects of stereotactic radiosurgery in treating patients with locally advanced or recurrent head and neck cancer.
Interventions
- RADIATION stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-01 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00851253
The ClinicalTrials.gov registry entry for NCT00851253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stereotactic radiosurgery is the first listed.
NCT00851253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00851253 about?
NCT00851253 is a clinical study titled "Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer". RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects of stereotactic radiosurgery in treating patients with locally advanced or recurrent head and neck cancer.
What is the current status of trial NCT00851253?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT00851253?
The interventions under investigation include: stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00851253?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.